XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income $ (172.0) $ 832.3
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation 189.4 168.9
Amortization of intangibles 54.4 43.3
Stock compensation expense 21.3 37.5
Impairment charges 5.3 0.0
Loss on business held for sale 497.8 0.0
Equity in net earnings of affiliates, net of cash received (37.3) (53.0)
Deferred income tax benefit (30.7) (55.2)
Other 24.9 17.1
Changes in operating assets and liabilities:    
Accounts and notes receivable, net (102.4) (481.6)
Inventories, net (221.1) (542.9)
Other current and noncurrent assets (79.7) (140.6)
Accounts payable (77.4) (56.1)
Accrued expenses (286.2) 251.8
Other current and noncurrent liabilities 105.7 181.2
Total adjustments 64.0 (629.6)
Net cash provided by (used in) operating activities (108.0) 202.7
Cash flows from investing activities:    
Purchases of property, plant and equipment (279.3) (357.7)
Proceeds from sale of property, plant and equipment 1.8 5.2
Purchase of businesses, net of cash acquired (1,902.2) (0.9)
Investments in unconsolidated affiliates, net (1.6) (21.3)
Other (0.2) (4.0)
Net cash used in investing activities (2,181.5) (378.7)
Cash flows from financing activities:    
Proceeds from indebtedness 2,624.6 725.5
Repayments of indebtedness (2.3) (148.5)
Payment of dividends to stockholders (251.5) (435.8)
Payment of minimum tax withholdings on stock compensation (11.9) (20.5)
Payment of debt issuance costs (15.7) (9.5)
Investments by noncontrolling interests, net 8.1 0.0
Net cash provided by financing activities 2,351.3 111.2
Effects of exchange rate changes on cash, cash equivalents and restricted cash (14.7) (44.0)
Increase (decrease) in cash, cash equivalents and restricted cash 47.1 (108.8)
Cash, cash equivalents and restricted cash, beginning of period 595.5 789.5
Cash, cash equivalents and restricted cash, end of period [1] $ 642.6 $ 680.7
[1] Includes $20.0 million of cash and cash equivalents classified as held for sale as of September 30, 2024.